BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 10274623)

  • 1. Therapeutic apheresis: treatment in search of a disease.
    J Health Care Technol; 1985; 1(4):279-98. PubMed ID: 10274623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quo vadis haemapheresis. Current developments in haemapheresis.
    Borberg H
    Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Canadian apheresis registry.
    Rock G; Clark B; Sutton D; ;
    Transfus Apher Sci; 2003 Oct; 29(2):167-77. PubMed ID: 12941357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of donating multiple products in a single apheresis collection: are we expecting too much?
    Strauss RG
    J Clin Apher; 2003; 18(3):135-40. PubMed ID: 14569607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of hyperviscosity by apheresis.
    Zarkovic M; Kwaan HC
    Semin Thromb Hemost; 2003 Oct; 29(5):535-42. PubMed ID: 14631553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World apheresis registry report.
    Stegmayr B; Ptak J; Wikström B
    Transfus Apher Sci; 2007 Feb; 36(1):13-6. PubMed ID: 17234456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical considerations for planning a therapeutic apheresis procedure.
    Shelat SG
    Am J Med; 2010 Sep; 123(9):777-84. PubMed ID: 20541168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apheresis technologies and clinical applications: the 2000 International Apheresis Registry.
    Malchesky PS; Koo AP; Rybicki LA
    Ther Apher; 2001 Jun; 5(3):193-206. PubMed ID: 11467756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of adverse effects during hemapheresis.
    Strauss RG
    J Clin Apher; 1996; 11(3):160-4. PubMed ID: 8915821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of Therapeutic Apheresis in Patients with Malignant Disease.
    Pineda AA; Vamvakas EC
    Oncologist; 1997; 2(2):94-103. PubMed ID: 10388036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
    Szczepiorkowski ZM; Bandarenko N; Kim HC; Linenberger ML; Marques MB; Sarode R; Schwartz J; Shaz BH; Weinstein R; Wirk A; Winters JL; ;
    J Clin Apher; 2007 Jun; 22(3):106-75. PubMed ID: 17394188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of blood purification techniques.
    Stegmayr BG
    Transfus Apher Sci; 2005 Apr; 32(2):209-20. PubMed ID: 15784456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications.
    Linenberger ML; Price TH
    J Intensive Care Med; 2005; 20(2):88-103. PubMed ID: 15855221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apheresis techniques for collection of peripheral blood progenitor cells.
    Moog R
    Transfus Apher Sci; 2004 Dec; 31(3):207-20. PubMed ID: 15556469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing (yin-yang) hypothesis for assessment of effective apheresis therapies.
    Nosé Y
    Ther Apher; 1999 Nov; 3(4):280-6. PubMed ID: 10608718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood component collection by apheresis.
    Burgstaler EA
    J Clin Apher; 2006 Jul; 21(2):142-51. PubMed ID: 15880369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic apheresis in critically ill patients.
    Sanford KW; Balogun RA
    J Clin Apher; 2011; 26(5):249-51. PubMed ID: 21834079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The technique of therapeutic apheresis. Removal of abnormal blood elements may succeed when all else fails.
    McLeod BC
    J Crit Illn; 1991 May; 6(5):487-95. PubMed ID: 10147917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Category IV indications for therapeutic apheresis: ASFA fourth special issue.
    Shaz BH; Linenberger ML; Bandarenko N; Winters JL; Kim HC; Marques MB; Sarode R; Schwartz J; Weinstein R; Wirk A; Szczepiorkowski ZM
    J Clin Apher; 2007 Jun; 22(3):176-80. PubMed ID: 17377982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.